Trimarchi Thomas
SEC insider (Form 3/4/5 filer). CIK 0002030813. President and CFO at BridgeBio Pharma, Inc. (BBIO). 21 reported Form 4/5 transactions since Sep 2024; latest on Aug 16, 2026. Located in PALO ALTO, CA.
Companies Trimarchi Thomas has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Officer, President and CFO
Trimarchi Thomas
CIK: 0002030813
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BridgeBio Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Aug 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect22.8K shares at avg. $79.86$1.8M - May 18, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect3.2K shares at avg. $65.95$211K - May 18, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect10.5K shares at avg. $64.82$678K - May 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect22.8K shares at avg. $66.13$1.5M - Mar 18, 2026BBIO
BridgeBio Pharma, Inc.
AwardDirect59K shares- - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect200 shares at avg. $75.38$15K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect13.4K shares at avg. $74.71$1.0M - Feb 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect18.8K shares at avg. $75.25$1.4M - Dec 12, 2025BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect13.8K shares at avg. $75.15$1.0M - Nov 17, 2025BBIO
BridgeBio Pharma, Inc.
SaleDirect7K shares at avg. $66.84$465K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 22,781 | $79.86 | $1,819,291 | Direct |
| May 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 3,195 | $65.95 | $210,712 | Direct |
| May 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 10,456 | $64.82 | $677,707 | Direct |
| May 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 22,781 | $66.13 | $1,506,508 | Direct |
| Mar 18, 2026 | BBIO BridgeBio Pharma, Inc. | Award | 59,041 | - | $0 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 200 | $75.38 | $15,076 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 13,400 | $74.71 | $1,001,071 | Direct |
| Feb 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 18,819 | $75.25 | $1,416,130 | Direct |
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 13,826 | $75.15 | $1,039,024 | Direct |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 6,956 | $66.84 | $464,938 | Direct |
1-10 of 21 transactions